Dirk Oliver Wennmann
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ 9
- Nephrology top 5%
- Renal Diseases and Glomerulopathies 2
-
- Ubiquitin and proteasome pathways 4
- Amyloidosis: Diagnosis, Treatment, Outcomes 1
-
- Long-Term Effects of COVID-19 2
-
- COVID-19 and healthcare impacts 2
-
- COVID-19 and Mental Health 1
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 1
- Co-authors
- Joachim KremerskothenHermann PavenstädtThomas WeideHsiang‐Hao HsuLin ZhangShuping YangJixin DongYuanhong Chen
- Journals
- Hepatology (1 paper)Journal of the American Society of Nephrology (1 paper)Journal of Neurochemistry (1 paper)
- Partner nations
- GermanyUnited StatesAustralia
In The Last Decade
Dirk Oliver Wennmann
13 papers receiving 484 citations
Peers
Comparison fields: 5 of 65
- Cell Biology 255
- Nephrology 90
- Critical Care and Intensive Care Medicine 23
- Molecular Biology 230
- Aging 4
Countries citing papers authored by Dirk Oliver Wennmann
This map shows the geographic impact of Dirk Oliver Wennmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Oliver Wennmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Oliver Wennmann more than expected).
Fields of papers citing papers by Dirk Oliver Wennmann
This network shows the impact of papers produced by Dirk Oliver Wennmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Oliver Wennmann. The network helps show where Dirk Oliver Wennmann may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dirk Oliver Wennmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2022 | 0 | |
| 3 | 2021 | 17 | |
| 4 | 2020 | 10 | |
| 5 | 2020 | 10 | |
| 6 | 2019 | 39 | |
| 7 | 2018 | 35 | |
| 8 | 2017 | 36 | |
| 9 | 2014 | 82 | |
| 10 | 2014 | 55 | |
| 11 | 2014 | 49 | |
| 12 | 2013 | 42 | |
| 13 | 2013 | 53 | |
| 14 | 2012 | 51 |
About Dirk Oliver Wennmann
Dirk Oliver Wennmann is a scholar working on Cell Biology, Nephrology and Neurology, having authored 14 papers that have together received 489 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (9 papers), Ubiquitin and proteasome pathways (4 papers), Renal Diseases and Glomerulopathies (2 papers), Long-Term Effects of COVID-19 (2 papers), COVID-19 and healthcare impacts (2 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (1 paper), COVID-19 and Mental Health (1 paper) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper). The work is most often cited by research in Cell Biology (255 citations), Nephrology (90 citations) and Critical Care and Intensive Care Medicine (23 citations). Dirk Oliver Wennmann has collaborated with scholars based in Germany, United States and Australia. Frequent co-authors include Joachim Kremerskothen, Hermann Pavenstädt, Thomas Weide, Hsiang‐Hao Hsu, Hermann Pavenstädt, Lin Zhang, Shuping Yang, Jixin Dong, Yuanhong Chen and Beate Vollenbröker. Their work appears in journals such as Hepatology, Journal of the American Society of Nephrology and Journal of Neurochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.